2025-05-15 - Analysis Report
Okay, here's a draft report based on the information you provided.

**Report on Natera Inc (NTRA)**

**1. Relative Performance vs. S&P 500 (VOO)**

*   **Ticker:** NTRA
*   **Company Description:** Natera Inc. is a diagnostics company focusing on cell-free DNA testing.
*   **NTRA Cumulative Return:** 0.0
*   **VOO Cumulative Return:** 0.0
*   **Disparity:**
    *   Max: 0.0
    *   Min: 0.0
    *   Current: 0.0
    *   Relative Disparity: 0.0

**Analysis:**

Without actual return data, it's impossible to provide meaningful comparisons. All values are currently set to 0.0. If real historical data is provided, the relative disparity would indicate Natera's performance relative to the S&P 500 over the covered period.  A higher relative disparity suggests NTRA outperformed VOO during that specific timeframe, placing it higher in the range of past performance differences.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 0.0% | 0.0% | 0.0%  | 1.0  | 1.2   |
| 2016-2018  | 0.0% | 0.0% | 0.0%  | 1.0  | 1.9   |
| 2017-2019  | 0.0% | 0.0% | 0.0%  | 1.0  | 4.6   |
| 2018-2020  | 0.0% | 0.0% | 0.0%  | 1.0  | 13.5  |
| 2019-2021  | 0.0% | 0.0% | 0.0%  | 1.0  | 12.7  |
| 2020-2022  | 0.0% | 0.0% | 0.0%  | 1.0  | 5.5   |
| 2021-2023  | 0.0% | 0.0% | 0.0%  | 1.0  | 8.5   |
| 2022-2024  | 0.0% | 0.0% | 0.0%  | 1.0  | 21.5  |
| 2023-2025  | 0.0% | 0.0% | 0.0%  | 1.0  | 20.7  |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** All CAGR values are 0.0%, indicating no growth over the specified periods.  This is based on the provided data.
*   **MDD (Maximum Drawdown):**  All MDD values are 0.0%, implying no losses during the specified periods based on the given data.
*   **Alpha:** Alpha is consistently 0.0, suggesting the stock has not outperformed its benchmark during these periods based on the provided data.
*   **Beta:** Beta is consistently 1.0, indicating the stock's volatility is similar to the market during these periods.
*   **Cap(B):** Represents the company's market capitalization in billions of dollars, showcasing growth and fluctuations over time.

**2. Recent Stock Price Movement**

*   **Current Price:** 152.27999877929688
*   **Last Market Data:** {'price': 151.41, 'previousClose': 152.28, 'change': -0.57}
*   **5-Day Moving Average:** 156.838
*   **20-Day Moving Average:** 152.8785
*   **60-Day Moving Average:** 149.9725

**Analysis:**

The stock price is slightly below the previous close. The 5-day moving average is higher than the 20-day and 60-day moving averages, which typically suggests an upward trend in the short term. However, the current price is below the 20-day moving average, which *could* indicate a recent pullback or a potential shift in momentum. The difference between the last price (151.41) and the previous close (152.28) shows a slight decrease (-0.57), indicating a minor downward pressure in the most recent trading session.

**3. Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.0 (This would be considered outside the typical ranges provided)
*   **RSI (Relative Strength Index):** 53.74697836719939
*   **PPO (Percentage Price Oscillator):** 0.0514
*   **Recent (20-day) Relative Divergence Change:** 0.0 (Short-term decline indicated)
*   **Expected Return (%):** 0.0 (Long-term excess return vs. S&P 500 if investing now)

**Analysis:**

*   **MRI:**  An MRI of 0.0 is outside the typical risk ranges provided. This might indicate extremely low risk (or a data error).  The provided risk categories are: Low Risk (0.45-0.35), Medium Risk (0.4-0.3), High Risk (0.5-0.65).
*   **RSI:** An RSI of 53.75 is neutral, suggesting neither overbought nor oversold conditions.
*   **PPO:** A PPO of 0.0514 indicates a slight upward trend in momentum.
*   **Recent Divergence Change:** A divergence change of 0.0 suggests a short-term downtrend.
*   **Price Change Impact:**  The price change is -0.57, which is a moderate decrease, suggesting a minor negative impact on the stock.
*   **Expected Return:** An expected return of 0.0% indicates no projected excess return compared to the S&P 500 based on the provided data and analysis.

**4. Recent News & Significant Events**

*   **[2025-05-13]** - Natera Inc (NTRA) has recently made headlines due to major business developments, regulatory changes, or market events.
*   **[2025-05-12]** - Analysts are discussing Natera Inc's (NTRA) recent performance and its outlook in the context of industry trends and global economic factors.
*   **[2025-05-14]** - Natera Inc (NTRA)'s stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-05-15]** - Market experts highlight both risks and opportunities for Natera Inc (NTRA), advising investors to monitor recent news and company announcements.

**Analysis:**

Recent news suggests potential catalysts and volatility around NTRA. Investors should monitor specific announcements for details on business developments, regulatory changes, earnings, and executive actions.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-05-09 | -0.5  | 0.50 B$    |
| 2024-11-12 | -0.26 | 0.44 B$    |
| 2024-08-09 | -0.3  | 0.41 B$    |
| 2024-05-10 | -0.56 | 0.37 B$    |
| 2025-05-09 | -0.56 | 0.37 B$    |

**Analysis:**

*   **EPS (Earnings Per Share):** NTRA is consistently reporting negative EPS, indicating losses.
*   **Revenue:** Revenue is growing, suggesting the company is increasing sales, although it has some duplicate dates on earnings analysis.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-03-31   | $0.50B   | 63.12%        |
| 2024-12-31   | $0.48B   | 62.94%        |
| 2024-09-30   | $0.44B   | 61.79%        |
| 2024-06-30   | $0.41B   | 58.83%        |
| 2024-03-31   | $0.37B   | 56.72%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE    |
|--------------|----------|--------|
| 2025-03-31   | $1.24B   | -5.40% |
| 2024-12-31   | $1.20B   | -4.50% |
| 2024-09-30   | $0.88B   | -3.60% |
| 2024-06-30   | $0.84B   | -4.48% |
| 2024-03-31   | $0.79B   | -8.51% |

**Analysis:**

*   **Revenue:** Revenue is steadily increasing, demonstrating positive growth in sales.
*   **Profit Margin:** Profit margins are high and improving, indicating efficient operations and pricing.
*   **Equity:** Equity is growing, suggesting the company is increasing its net worth.
*   **ROE (Return on Equity):** ROE is negative, reflecting the company's net losses relative to its equity. Although negative, ROE is trending towards less negative values, which aligns with the growth in revenue and increasing profit margin.

**7. Summary Analysis**

Based on the provided data:

*   Natera (NTRA) is a diagnostics company experiencing revenue growth and improving profit margins.
*   However, the company is currently unprofitable, as indicated by negative EPS and ROE.
*   Recent stock price movement suggests a slight pullback, but the short-term trend has been upward based on moving averages.
*   Technical indicators are neutral to slightly positive.
*   Recent news highlights potential catalysts and volatility.
*   Analysts are discussing the company's performance and outlook, suggesting investors monitor news and company announcements.
*   The company has a consistently high Beta, meaning it generally moves in sync with the market.

**Overall, NTRA presents a mixed picture. It is growing its revenue and improving its operations, but it has not yet achieved profitability. Investors should carefully consider the company's financial performance, recent news, and market conditions before making investment decisions.**
